Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data.

MLA

Derigs, Patrick, et al. “Letermovir Prophylaxis Is Effective in Preventing Cytomegalovirus Reactivation after Allogeneic Hematopoietic Cell Transplantation: Single-Center Real-World Data.” Annals of Hematology, vol. 100, no. 8, Aug. 2021, pp. 2087–93. EBSCOhost, https://doi.org/10.1007/s00277-020-04362-2.

APA

Derigs, P., Radujkovic, A., Schubert, M.-L., Schnitzler, P., Schöning, T., Müller-Tidow, C., Hegenbart, U., Schönland, S. O., Luft, T., Dreger, P., & Schmitt, M. (2021). Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data. Annals of Hematology, 100(8), 2087–2093. https://doi.org/10.1007/s00277-020-04362-2

Chicago

Derigs, Patrick, Aleksandar Radujkovic, Maria-Luisa Schubert, Paul Schnitzler, Tilman Schöning, Carsten Müller-Tidow, Ute Hegenbart, et al. 2021. “Letermovir Prophylaxis Is Effective in Preventing Cytomegalovirus Reactivation after Allogeneic Hematopoietic Cell Transplantation: Single-Center Real-World Data.” Annals of Hematology 100 (8): 2087–93. doi:10.1007/s00277-020-04362-2.